T42.8
Poisoning by, adverse effect of and underdosing of antiparkinsonism drugs and other central muscle-tone depressants
Clinical Classification Guidelines
Inclusion Terms
- Poisoning by, adverse effect of and underdosing of amantadine
Medical Intelligence & Overview
ICD-10 code T42.8 covers medical situations involving poisoning, adverse effects, or underdosing of antiparkinsonism drugs and other central muscle-tone depressants. These medications are primarily used to manage Parkinson's disease and other neurological conditions. Proper understanding of this code helps in accurately documenting and managing cases related to drug reactions or toxicity, especially concerning amantadine, a common medication in this category. Recognizing the symptoms and causes linked to these drug reactions can support healthcare providers in delivering appropriate care and interventions.
Causes & Symptoms
Clinical Causes: Ingesting higher-than-prescribed doses of antiparkinsonism medications, leading to toxicity. Adverse reactions developing despite correct dosing, due to individual sensitivities or interactions with other drugs. Accidental ingestion by children or individuals with cognitive impairments. Underdosing or missed doses resulting in treatment failure or rebound symptoms. Switching medications or formulations without proper medical guidance, causing unintended effects. Drug interactions with other prescribed or over-the-counter medications increasing risk of adverse reactions. Prolonged use of these drugs, leading to cumulative toxicity or side effects.
Key Symptoms: Dizziness or lightheadedness Muscle weakness or tremors Confusion or altered mental state Hallucinations or psychosis Nausea and vomiting Drowsiness or sedation Changes in blood pressure, either hypertension or hypotension Unusual movements or dyskinesias Respiratory difficulties in severe cases Signs of overdose such as unconsciousness or seizures
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive clinical assessment, including review of medication history and recent doses. Healthcare providers may perform physical and neurological examinations to evaluate muscle tone, mental status, and coordination. Laboratory tests, including blood and urine analyses, can detect drug levels and rule out other conditions. In some cases, imaging studies or additional neurological assessments may be employed to exclude other causes of symptoms.
Treatment Protocols: Treatment strategies depend on the severity of the adverse reaction or poisoning. They may include:
Clinical Advice & FAQs
Billing Guidance
Is T42.8 a billable ICD-10 code?
Yes, T42.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T42.8?
Clinical documentation must specify the nature of Poisoning by, adverse effect of and underdosing of antiparkinsonism drugs and other central muscle-tone depressants and any associated comorbidities for accurate reporting.
Cite this Clinical Reference